{
  "id": 130196,
  "title": "Why There's a Shortage of Chemotherapy Drugs",
  "url": "https://urgent.news/2026/08/04/why-theres-a-shortage-of-chemotherapy-drugs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-04T13:20:00.000Z",
  "source": {
    "name": "Time",
    "slug": "time",
    "url": "https://time.com/article/2026/08/04/chemotherapy-drug-shortage/"
  },
  "original_language": "en",
  "account": "A shortage of chemotherapy drugs, including cisplatin and carboplatin, has persisted since 2023, posing potential risks to cancer patients. These two drugs, introduced in 1978 and 1986 respectively, are crucial for treating various types of cancer and are prescribed to up to 20% of patients. However, hospital pharmacists have faced difficulties sourcing these essential medications, leading doctors to provide less optimal alternatives or adjust treatment schedules. The U.S. Pharmacopeia's latest report reveals that the average duration of drug shortages for all categories has more than doubled since 2019. The root cause of this issue lies in the economic aspects of drug production and procurement. Hospitals often pay minimal prices for these life-saving drugs, making it financially unviable for manufacturers to continue production. Moreover, these chemotherapy drugs require specialized sterile facilities and expertise to manufacture, but since they are off-patent or generic, any company can produce them and set market prices. Consequently, hospitals seek the lowest-priced sources, which can lead to manufacturers repurposing facilities for higher-margin drugs, reducing the availability of chemotherapy drugs. Additionally, key ingredients and finished products for these drugs often come from a few countries, creating a fragile supply chain. The war in Iran has further disrupted production, with some manufacturers struggling to obtain essential ingredients. Experts suggest that hospitals should be incentivized to pay more for ensuring a resilient supply chain and recommend moving towards a more diversified, resilient supply chain to avoid compromising cancer care.",
  "summary": "Essential cancer medications are getting more difficult for hospitals to source, experts say.",
  "key_points": [
    "Shortage of cisplatin and carboplatin drugs since 2023",
    "Hospital pharmacists struggle to source essential medications",
    "Economic factors and supply chain fragility cause drug shortage"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}